Prediction of short-term progression of COVID-19 pneumonia based on chest CT artificial intelligence: during the Omicron epidemic.

Journal: BMC infectious diseases
Published Date:

Abstract

BACKGROUND AND PURPOSE: The persistent progression of pneumonia is a critical determinant of adverse outcomes in patients afflicted with COVID-19. This study aimed to predict personalized COVID-19 pneumonia progression between the duration of two weeks and 1 month after admission by integrating radiological and clinical features.

Authors

  • Xinjing Lou
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Chen Gao
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • Linyu Wu
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • Ting Wu
    Asia Pacific Unit, Department of Pharmacoepidemiology, MSD (China) R&D Co., Ltd., Beijing, China.
  • Linyang He
    Hangzhou Jianpei Technology Co., Ltd, Hangzhou, China.
  • Jiahao Shen
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 54 Youdian Road, Hangzhou, Zhejiang, 310006, China.
  • Meiqi Hua
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 54 Youdian Road, Hangzhou, Zhejiang, 310006, China.
  • Maosheng Xu
    Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.